Trial intelligence / Profile preview

Electroacupuncture Combined With Donepezil in Alzheimer's Disease

NCT02305836Phase 2Unknown

Sponsor
Guang'anmen Hospital
Start
Jun 2017
Primary completion
Jun 2019
Countries
1
01

Overview

Phase 2, randomised, single-blind trial (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale at 12 weeks. Status: unknown.

Beyond the preview

Go deeper on NCT02305836.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02305836.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call